期刊文献+

老年代谢综合征患者的临床特点分析 被引量:12

Clinical Characteristics of the Elderly with Metabolic Syndrome
下载PDF
导出
摘要 目的探讨老年2型糖尿病患者合并代谢综合征(MS)的临床特征及对糖尿病大血管病变及肾脏损害的影响。方法选择2型糖尿病患者257例,分为合并代谢综合征组(MS组,120例)和非代谢综合征组(非MS组,137例),对比分析2组患者的临床资料及冠状动脉粥样硬化性心脏病(简称冠心病)、下肢动脉硬化、脑梗死的发病情况。结果代谢综合征组患者的体质量指数(BMI)、胰岛素抵抗值、胆固醇、三酰甘油均较非代谢综合征组明显增高,MS组β细胞功能较非MS组差,差异有统计学意义(P<0.01);代谢综合征组患者尿酸及尿白蛋白排泄率较非代谢综合征组均明显增高,差异有统计学意义(P<0.01),代谢综合征组冠心病的发病比例显著高于非代谢综合征组(P<0.05)。结论与非代谢综合征组的老年2型糖尿病患者比较,合并代谢综合征患者的β细胞功能较差、胰岛素抵抗及肾脏损害较重,冠心病发生率更高。 Objective To investigate clinical characteristics of the elderly with metabolic syndrome and type 2 diabetes and the influence of metabolic syndrome on coronary heart disease and chronic renal disease. Methods The study was conducted in 257 patients ( age range 60-85 years) with type 2 diabetes mellitus. The patients were divided into two groups which were with or without MS according to the Adult Treatment Panel Ⅲ criteria :120 patients with MS and 137 patients without MS. The clinical features and morbidity of coronary heart disease, arteriosclerosis of the lower extremity, and cerebral infarction. Results Compared with patients without MS, BMI, HOMA-β, total cholesterol, triglyceride, uric acid and microalbuminuria of patients with MS were significantly higher( all P 〈 0.01 ). Compared with patients without MS, more patients with MS suffered from CHD ( P 〈 0.01 ). Conclusion Obesity, dyslipidemia, insulin resistance, hyperuricacidemia, microalbuminuria and CHD were more common in the elderly with MS and type 2 diabetes.
出处 《首都医科大学学报》 CAS 北大核心 2009年第5期691-695,共5页 Journal of Capital Medical University
关键词 2型糖尿病 代谢综合征 微量白蛋白尿 冠状动脉粥样硬化性心脏病 type 2 diabetes mellitus metabolic syndrome microalbuminuria coronary heart disease
  • 相关文献

参考文献17

  • 1Song Y,Manson J E,Meigs J B,et al.Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women[J].Am J Cardiol,2007,100:1654-1658.
  • 2Sundstrom J,Risérus U,Byberg L,et al.Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality:prospective,population based cohort study[J].BMJ,2006,332:878-882.
  • 3Chen J,Muntner P,Harem L L,et al.The metabolic syndrome and chronic kidney disease in U.S.adults[J].Ann Intern Med,2004,140:167-174.
  • 4World Health Organization.Definition,diagnosis and classification of diabetes mellitus and its complications,part 1:diagnosis and classification of diabetes mellitus[S].Geneva:WHO,1999.
  • 5Molitch M E,DeFronzo R A,Franz M J,et al.Nephropathy in diabetes[J].Diabetes Care,2004,27:s79-83.
  • 6Sowers J R.Insulin resistance and hypertension[J].Am J Physiol Heart Cric Physiol,2004,286:H1597-H1602.
  • 7Niskanen LK,Laaksonen D E,Nyyssonen K,et al.Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study[J].Arch Intern Med,2004,164:1546-1551.
  • 8Gu D,Reynolds K,Wu X,et al.Prevalence of the metabolic syndrome and overweight among adults in China[J].Lancet,2005,365:1398-1405.
  • 9张波,沈淑琼,胡伟新,陈惠萍.肥胖与肾脏病[J].肾脏病与透析肾移植杂志,2002,11(3):277-282. 被引量:28
  • 10刘志红,黄燕飞.胰岛素抵抗与糖尿病肾病[J].肾脏病与透析肾移植杂志,2002,11(2):164-167. 被引量:36

二级参考文献12

共引文献161

同被引文献98

引证文献12

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部